5 amino 1mq clinical trial 5-AMINO-1MQ 5-Amino-1MQ Research Compound | >99%

Unlike full-length hGH, AOD-9604 has been found not to raise IGF-1 levels and does not affect insulin sensitivity

Qualified staff follow safety protocols to help ensure a positive and comfortable experience

Published safety profile remained clean Phase IIb: Larger cohort, confirmed dose-response

On top of this, you have to track your doses, store your vials properly, and manage complete sterility throughout the process

Reconstitute 3.0 mL BAC water Concentration 4.33 mg/mL total blend 10 units draw 0.10 mL = ~0.43 mg total Typical cycle 8-16 weeks Dose selector Component Delivery - 10/3 Vial The 10/3 vial keeps tesamorelin as the lead compound